Efficacy and prognosis of surgical treatment in ARMM and its effects on immune and inflammatory profiles

Huan,Mei; Tian,Wei; Zhang,Zhixia

doi:10.3892/etm.2020.9407

Efficacy and prognosis of surgical treatment in ARMM and its effects on immune and inflammatory profiles

Authors:
- Mei Huan
- Wei Tian
- Zhixia Zhang
View Affiliations

Affiliations: Operating Room, Linyi Cancer Hospital, Linyi, Shandong 276000, P.R. China, Outpatient Department, Linyi Cancer Hospital, Linyi, Shandong 276000, P.R. China, Department of Breast Surgery, Linyi Cancer Hospital, Linyi, Shandong 276000, P.R. China
Published online on: October 27, 2020 https://doi.org/10.3892/etm.2020.9407
Article Number: 277

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the efficacy and prognosis of surgical treatment in anorectal malignant melanoma (ARMM) as well as its effects on immune and inflammatory profiles. A total of 64 patients with ARMM were enrolled and divided into control group (n=32) and observation group (n=32) based on different therapeutic methods. Patients in the observation group underwent wide local excision, while those in the control group were given non‑surgical treatment. The immune function was compared between the two groups after treatment. The expression levels of serum IL‑17, IL‑23 and vascular endothelial growth factor (VEGF) were compared between the groups before and after treatment. Patients were followed up for 5 years to observe the recurrence and survival rates in the two groups. Compared with those in the control group, the levels of cluster of differentiation (CD)3⁺, CD4⁺ and CD4⁺/CD8⁺ were increased, while the level of CD8⁺ was reduced in the observation group (P<0.05). The levels of serum IL‑17, IL‑23 and VEGF were significantly lower in both groups at 4, 6 and 8 weeks after treatment than those before treatment, and the decrease was more obvious in the observation group (P<0.05). The observation group exhibited a notably elevated 5‑year survival rate and a remarkably decreased recurrence rate in comparison with the control group (P<0.05). For ARMM, surgical treatment is more effective than non‑surgical treatment, which has less effect on immune function, is able to reduce serum IL‑17, IL‑23 and VEGF levels, lower recurrence rate, improve patient survival rate, and plays a certain positive role in prolonging the survival time of ARMM patients.

View Figures

View References

1	Latteri S, Teodoro M, Malaguarnera M, Mannino M, Currò G and La Greca G: Abdominal perineal resection or Wilde local excision in primary anorectal malignant melanoma. Case report and review. Ann Med Surg (Lond). 19:74–77. 2017.PubMed/NCBI View Article : Google Scholar
2	Tokuhara K, Nakatani K, Tanimura H, Yoshioka K, Kiyohara T and Kon M: A first reported case of metastatic anorectal amelanotic melanoma with a marked response to anti-PD-1 antibody nivolumab: A case report. Int J Surg Case Rep. 31:188–192. 2017.PubMed/NCBI View Article : Google Scholar
3	Zaiem F and Alrifai A: Anorectal malignant melanoma presenting as acute pancreatitis. Am J Med Sci. 354:327–328. 2017.PubMed/NCBI View Article : Google Scholar
4	Ohta R, Inoue T, Goto M, Tachimori Y and Sekikawa K: Combined laparoscopic abdomino-endoscopic perineal total mesorectal excision for anorectal malignant melanoma: A case report. Int J Surg Case Rep. 44:135–138. 2018.PubMed/NCBI View Article : Google Scholar
5	Seo KI, Moon W, Kim SE, Park MI and Park SJ: Malignant melanoma of the anus found during routine colonoscopy in ulcerative colitis. Korean J Gastroenterol. 69:368–371. 2017.PubMed/NCBI View Article : Google Scholar
6	Jesinghaus M, Steiger K, Slotta-Huspenina J, Drecoll E, Pfarr N, Meyer P, Konukiewitz B, Bettstetter M, Wieczorek K, Ott K, et al: Increased intraepithelial CD3⁺ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. Oncotarget. 8:46756–46768. 2017.PubMed/NCBI View Article : Google Scholar
7	Wang L and Shen Y: Imbalance of circulating T-lymphocyte subpopulation in gastric cancer patients correlated with performance status. Clin Lab. 59:429–433. 2013.PubMed/NCBI
8	Karabulut M, Usul AC, Serimez M and Karabulut S: Serum IL-17 levels can be diagnostic for gastric cancer. J BUON. 24:1601–1609. 2019.PubMed/NCBI
9	Tang WJ, Tao L, Lu LM, Tang D and Shi XL: Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma. Oncol Lett. 14:561–568. 2017.PubMed/NCBI View Article : Google Scholar
10	Treskova I, Topolcan O, Windrichova J, Simanek V, Slouka D, Treska V and Kucera R: OPG, OPN, EGF and VEGF levels at individual Breslow score stages in malignant melanoma. Anticancer Res. 38:4907–4911. 2018.PubMed/NCBI View Article : Google Scholar
11	Kumar U and Singhal U: Anorectal melanoma: An unusual cause of rectal bleeding. J Clin Diagn Res. 11:D12–D13. 2017.PubMed/NCBI View Article : Google Scholar
12	Yang J, Xiao P, Sun J and Guo L: Anticancer effects of kaempferol in A375 human malignant melanoma cells are mediated via induction of apoptosis, cell cycle arrest, inhibition of cell migration and downregulation of m-TOR/PI3K/AKT pathway. J BUON. 23:218–223. 2018.PubMed/NCBI
13	Ranjith S, Muralee M, Sajeed A, Arun PM, Cherian K, Nair CK, Augustine P and Ahamed I: Anorectal melanoma: Experience from a tertiary cancer care centre in South India. Ann R Coll Surg Engl. 100:185–189. 2018.PubMed/NCBI View Article : Google Scholar
14	Bulut N, Dagistanli S, Yilmaz B and Atay OF: Surgical approach to anorectal melanoma with PET-CT staging: A case report. Surg J (NY). 3:e177–e180. 2017.PubMed/NCBI View Article : Google Scholar
15	Cai ED and Kim J: Identification of novel targetable mutations in metastatic anorectal melanoma by next-generation sequencing. JAAD Case Rep. 3:539–541. 2017.PubMed/NCBI View Article : Google Scholar
16	Virgilio E, Mercantini P, Santangelo G, Canali G, Peritore V and Balducci G: Anorectal melanoma: A rare aggressive type of melanoma. Anz J Surg. 87:421–422. 2017.PubMed/NCBI View Article : Google Scholar
17	Sousa IG, Do AM, Simi KC, Bezerra MA, Andrade RV, Maranhao AQ and Brigido MM: MicroRNA expression profiles in human CD3(+) T cells following stimulation with anti-human CD3 antibodies. BMC Res Notes. 10(124)2017.PubMed/NCBI View Article : Google Scholar
18	Hofmann H: A foot tumour as late cutaneous lyme borreliosis: A new entity or a variant of an inflammatory proliferative reaction to borrelia burgdorferi? Br J Dermatol. 177:906–907. 2017.PubMed/NCBI View Article : Google Scholar
19	Nie W, Yu T, Sang Y and Gao X: Tumor-promoting effect of IL-23 in mammary cancer mediated by infiltration of M2 macrophages and neutrophils in tumor microenvironment. Biochem Biophys Res Commun. 482:1400–1406. 2017.PubMed/NCBI View Article : Google Scholar
20	Amicarella F, Muraro MG, Hirt C, Cremonesi E, Padovan E, Mele V, Governa V, Han J, Huber X, Droeser RA, et al: Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. Gut. 66:692–704. 2017.PubMed/NCBI View Article : Google Scholar